Estimating the lifetime economic burden of Parkinson's disease in Singapore

Estimating the lifetime economic burden of Parkinson's disease in Singapore

10.1111/j.1468-1331.2012.03868.x

Saved in:

Bibliographic Details
Main Authors:	Zhao, Y.J., Tan, L.C.S., Au, W.L., Heng, D.M.K., Soh, I.A.L., Li, S.C., Luo, N., Wee, H.L.
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format:	Article
Published:	2014
Subjects:	Cost of illness Modelling Parkinson's disease Pharmacoeconomics
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/52919
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Economic burden of Parkinson's disease in Singapore
by: Zhao, Y.J., et al.
Published: (2014)

Lifetime direct medical costs of childhood obesity
by: Finkelstein, E.A., et al.
Published: (2014)

Pharmacoeconomics and health outcomes research for Hepatitis B virus infection in Singapore
by: ONG SIEW CHIN
Published: (2010)

Health related quality of life and pharmacoeconomics amongst Asian parkinson¿s disease patients in Singapore
by: ZHAO YINGJIAO
Published: (2011)

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
by: Zhao, Y.J., et al.
Published: (2011)

Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times
by: Zhao, Y.J., et al.
Published: (2014)

Health and economic burden of hpv-related diseases in singapore
by: Low, J.J.H., et al.
Published: (2014)

Role of pharmacoeconomics in formulary decision-making
by: ANUJA NIDUMOLU ROY
Published: (2010)

HEALTH TECHNOLOGY ASSESSMENT OF NEW MODELS IN HEALTHCARE
by: RITIKA KAPOOR
Published: (2018)

Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease
by: Zhao, Y.J., et al.
Published: (2011)

Medical and economic burden of chronic hepatitis B patients at Queen Savang Vadhana Memorial Hospital
by: Chuenrutai Yeekian
Published: (2023)

A new population-based measure of the economic burden of mental illness in Canada
by: Lim, K.-L., et al.
Published: (2011)

Cognitive decline in early Parkinson's disease
by: Kandiah, N., et al.
Published: (2015)

Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index
by: Cheung, Y.B., et al.
Published: (2011)

Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore
by: Lee, K.-H., et al.
Published: (2011)

Validity and reliability of the Chinese (Singapore) version of the Parkinson's Disease Questionnaire (PDQ-39)
by: Luo, N., et al.
Published: (2014)

Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore
by: Luo, N., et al.
Published: (2011)

What Is Next for Pharmacoeconomics and Outcomes Research in Asia?
by: Doherty, J., et al.
Published: (2014)

Determination of the longitudinal validity and minimally important difference of the 8-item Parkinson's disease questionnaire (PDQ-8)
by: Luo, N., et al.
Published: (2011)

A longitudinal study of non-motor symptom burden in Parkinson's disease after a transition to expert care
by: Prakash K.M., et al.
Published: (2018)

Structural connectome alterations in prodromal and de novo Parkinson's disease patients
by: Wen M.-C., et al.
Published: (2018)

Association of HLA locus variant in parkinson's disease
by: Zhao, Y., et al.
Published: (2014)

Analysis of EIF4G1 in Parkinson's disease among Asians
by: Zhao, Y., et al.
Published: (2014)

Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease
by: Wen M.-C., et al.
Published: (2018)

Depression, anxiety, and apathy in Parkinson's disease: Insights from neuroimaging studies
by: Wen M.-C., et al.
Published: (2018)

A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
by: Wong, AW, et al.
Published: (2022)

Direct costs of myopia in Singapore
by: Lim, M.C.C., et al.
Published: (2014)

Linking statins and lipids in Parkinson's disease
by: Ng A.S.L., et al.
Published: (2018)

Acupuncture in the treatment of fatigue in Parkinson's disease: A pilot, randomized, controlled, study
by: Kong, K.H, et al.
Published: (2020)

True Difference or Something Else? Problems in Cost of Osteoarthritis Studies
by: Xie, F., et al.
Published: (2014)

Positive predictive value of different methods for identifying Parkinson's disease cases in an epidemiological study
by: Abbas M.M., et al.
Published: (2018)

Ubiquitin-proteasome system dysfunction in Parkinson's disease: Current evidence and controversies
by: Lim, K.-L.
Published: (2014)

How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore
by: Ong, S.C., et al.
Published: (2014)

Cerebral white matter hyperintensity in Parkinson's disease: A major risk factor for mild cognitive impairment
by: Kandiah, N., et al.
Published: (2016)

The characteristics of patients associated with high caregiver burden in Parkinson's disease in Singapore
by: Tan, M.M.J., et al.
Published: (2021)

Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore
by: Tan, L.C.S., et al.
Published: (2014)

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
by: Tan E.K., et al.
Published: (2018)

No association of DNM3 with age of onset in Asian Parkinson's disease
by: Foo J.N., et al.
Published: (2018)

Mild cognitive impairment in Parkinson's disease: A distinct clinical entity?
by: Wen M.-C., et al.
Published: (2018)

Targeting LRRK2 in Parkinson's disease: an update on recent developments
by: Chan S.L., et al.
Published: (2018)